Trials / Terminated
TerminatedNCT00910273
Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients
Effects of Etanercept on Endothelial Function and Carotid Intima-media Thickness (IMT) in Patients With Active AS
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study to assess whether etanercept therapy is able to increase flow-mediated vasodilatation in AS, and whether etanercept can modify the intima-media thickness (IMT) in these patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etanercept | etanercept 50 mg/week |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2009-05-29
- Last updated
- 2016-01-13
- Results posted
- 2016-01-13
Locations
4 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00910273. Inclusion in this directory is not an endorsement.